The University of Malaya Medical Centre (UMMC) Ethics Committee (Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia) approved this study (MEC Ref no. 20149-534).
A convenience sampling of postgraduate students and staffs who were working at the Sports Medicine Clinic, UMMC, were invited to participate in this study. Participants consisted of healthy individuals who were free from any chronic illnesses and not taking any regular medication, including aspirin and nonsteroidal anti-inflammatory drugs. Prior to recruitment, the study objectives and procedures involved were explained to participants, and each signed an informed consent form. A total of 27 individuals who volunteered were screened prior to participation. All individuals fulfilled the inclusion criteria and consented to be included as participants in this study.
PRP preparation
The PRP preparation technique was adapted from previously published methods.21-23 Whole blood was drawn using a 21 G x 1.9 cm butterfly needle (Becton Dickinson & Co, Franklin Lakes, NJ) from the participant’s antecubital vein into 4 plain 6.0 mL BD Vacutainer tubes (Becton Dickinson & Co). Each tube was prefilled with 0.6 mL of the anticoagulant citrate dextrose solution-A to prevent collected blood from clotting. An additional 2 mL of whole blood was collected into an ethylenediaminetetraacetic acid (EDTA) tube to acquire baseline whole blood platelets and leukocytes (WBC) value. All 4 plain tubes were centrifuged at 3200 RPM for 10 minutes using a table top Horizon Model 755VES centrifuge (The Drucker Co, Port Matilda, PA; Figure 1). The speed and duration of the centrifugation process used in this study were based on work by previous researchers.21,23,24
After centrifugation, the tubes were placed in a test tube rack and allowed to rest for 5 minutes to facilitate the settling of platelets onto the buffy coat (Figure 2). The PRP was collected using a needle attached to a 5-mL syringe measuring 18 G x 4.5 cm under naked eye visualization. With the tube stoppers removed, the needle tip was positioned so as to just touch the buffy coat. The syringe plunger was gently raised to vacuum up platelets on the buffy coat, and the needle tip was slowly moved along the buffy layer (Figure 3).
A total volume of 0.5 mL to 0.75 mL buffy coat was extracted from each tube into the collection syringe. A total PRP of 2.0 mL to 3.0 mL per participant was collected and transferred into an EDTA tube for analysis. The amount of platelets and WBCs present in the venous blood and the PRP were determined using the Sysmex XN-10 and XN-20 (Sysmex Corporation, Kobe, Japan) high-performance automated hematology analyzer in the UMMC outpatient laboratory. The ratio of platelet levels in venous blood to PRP was calculated to determine the ability of the current method to concentrate platelets.
Statistical analysis
Data obtained were analyzed using SPSS software for Mac (Version 22; IBM Corp, Armonk, NY). Descriptive analysis of participants’ characteristics was performed. Continuous variables were reported using mean and standard deviation (SD) or median and interquartile range (IQR), depending on data distribution based on Shapiro-Wilk test of normality. Categorical data were presented as frequencies and percentages. Paired sample t test or its nonparametric equivalence test were performed to determine the differences in platelet and WBC content between the whole blood and PRP produced by the technique used herein.
In addition, platelet and WBC content produced using the current method were compared with those produced using GPS III Platelet Separation System (Biomet Inc, Warsaw, IN) from a previous study.10 For all analyses, a value of P < .05 was considered statistically significant.